Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine
Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine
复制标题
DOI：
10.1097/01.coc.0000143845.79889.33
复制
发表时间：
2005-04-01
影响因子：
2.6
通讯作者：
Doval, DC
中科院分区：
文献类型：
--
作者：
Pavithran, K;Doval, DC
白血病作为甲状腺癌治疗后的第二个恶性肿瘤是罕见的。文献报道的大多数病例发生在累积剂量高于800 mCi后，最常见的是急性白血病。我们报告一位40岁男性，在接受甲状腺乳头状癌治疗14年后，发生慢性粒细胞白血病。我们的患者在诊断CML和给予I-131之间的间隔时间最长。
Leukemia as a second malignancy after treatment of thyroid cancer is rare. Most cases reported in the literature-have occurred after cumulative doses higher than 800 mCi and it is most commonly acute leukemias. We report a case of chronic myeloid leukemia (CML) occurring in a 40-year-old man 14 years after treatment of papillary thyroid carcinoma. Our patient had the longest interval between the diagnosis of CML and administration of I-131.